A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

Clinical trial NCT05485974 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05485974
Sponsor: HUYABIO International, LLC.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Non Small Cell Lung Cancer Colorectal Cancer Cancer of Pancreas Colon Cancer Solid Tumor Cancer

Start date: 2022-08-01
Primary completion: 2026-12-31
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.